1 / 9

Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 | CAGR: 9.3%

The global cancer immunotherapy market size is expected to reach USD 117.82 billion by 2026 according to a new study by Polaris Market Research. The report u201cCancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report By Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators); By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer); By End-user (Hospital, Clinics, Others); By Regions, Segments Forecast, 2020 u2013 2026u201dgives a detailed insight into current market dynamics and provides analysis on future market growth.<br><br>

karishmamtip
Download Presentation

Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 | CAGR: 9.3%

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer Immunotherapy Market Set to Exceed $117.82 Billion By 2026 | CAGR 9.3.%

  2. Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 “Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report By Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators); By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer); By End-user (Hospital, Clinics, Others); By Regions, Segments & Forecast, 2020 - 2026” The global cancer immunotherapy market size is expected to reach USD 117.82 billion by 2026 according to a new study by Polaris Market Research. Increasing pool of patients and greater mortality rates through cancer worldwide have encourage the need for cancer immunotherapy. Cancer is the second leading cause mortalities in 2019, with continuous rise in the number of cancer patient across the globe, as per the report published by WHO. Furthermore, it is estimated that 1 out of 6 deaths occurs due to cancer every year across the globe. As per WHO, nearly one-third of the mortalities from cancer are due to 5 leading behavioral and dietary risk, which includes low fruit and vegetable intake, high body mass index, lack of physical activity, alcohol consumption, and tobacco use. Tobacco is one of the leading factors for the rise in the prevalence of cancer and mortalities that accounted to nearly 22% of the global population. Rising number of cancer patients is the major factor for the growth of global diagnostic biomarker market. According to WHO, in 2015, there were around 17.6 million cases related to cancer that increases to 18.1 million cases in 2018 and nearly 9.6 million mortalities. Cancer immunotherapy is widely used in treating prostate cancer, blood cancer, melanoma, lung, breast, colorectal and other chronic diseases. In the breast cancer segment, there is relatively higher demand for immunotherapy. The demand for immunotherapy in pulmonary cancer is also significantly increasing. Furthermore, the growing population of smokers and the alarming increase in urban air pollution are the main factors driving the market development. Therefore, increasing prevalence of cancer across the globe augmenting the global market for cancer immunotherapy. Browse Detailed Research Report On Cancer Immunotherapy Market Analysis: https://www.polarismarketresearch.com/industry-analysis/cancer-immunotherapy-market Moreover, the global market for cancer immunotherapy is driven by a growing amount of approvals for new immunotherapy drugs. In the global cancer therapy industry, cancer immunotherapy has led to unprecedented changes. Over the past few years, cancer immunotherapy has generated fresh waves of optimism across the global oncology industry, which has unmasked enormous innovative potential. Studies now look for fresh goals and procedures to overcome the lapses in conventional treatment after years of jostling about the way the body can use its immune system. The paradigm - 2 -

  3. Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 shift in the management of cancer, relative to existing conventional therapies based on features like relatively long-lived effects, exceptional specificity and enhanced survival rates was brought about by the introduction of cancer immunotherapy. This has led to the accelerated growth of the global market. Moreover, emerging market such as Asia-pacific has substantial opportunity in the market. The factors that will be favorable to the growth of the market in the emerging market includes increasing government expenditures on healthcare in Asian countries, and the presence of huge population suffering with colorectal cancer and other cancer types. The cancer cases in Asia are increasing at a rapid rate. According to the WHO, there were an estimated 4 million mortalities from cancer in Asia in 2016. Cancer is the leading cause of mortality in China as there are 4 million new cancer patients diagnosed every year. Request for sample: https://www.polarismarketresearch.com/industry-analysis/cancer- immunotherapy-market/request-for-sample The same condition is in South Korea, as there are more than 200,000 new cancer cases a year. The increase in cancer cases in Asia can be accounted to the lifestyle and demographic changes. According WHO The incidences of colorectal cancer India were estimated about 1,85,000 in 2017. Japan accounted 1,49,000 cases in the 2017 according to national cancer institute. The average annual increase in government healthcare spending in the US is 4.5% and less than 1.5% in the European Union. However, Asian countries increase in healthcare expenditure is more than 6%, which is higher than the developed nations. Japan has the highest growth in the healthcare. Thus, creating significant opportunity in the market. 1. TABLE OF CONTENTS 2. Overview and Scope 2.1. Research goal & scope 2.2. Research assumptions 2.3. Research Methodology 2.3.1. Primary data sources 2.4. Secondary data sources 2.5. Key take-aways 2.6. Stakeholders 3. Executive Summary 3.1. Market Definition 3.2. Market Segmentation 4. Cancer Immunotherapy Market Insights 4.1. Cancer Immunotherapy– Industry snapshot 4.2. Cancer Immunotherapy market dynamics 4.2.1. Cancer Immunotherapy– Market Forces 4.2.1.1. Cancer Immunotherapy Market driver analysis - 3 -

  4. Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 Cancer Immunotherapy Market restraint/challenges analysis Cancer Immunotherapy Market opportunity analysis 4.3. Industry analysis - Porter's five force 4.3.1. Bargaining power of supplier 4.3.2. Bargaining power of buyer 4.3.3. Threat of substitute 4.3.4. Threat of new entrant 4.3.5. Degree of competition 4.4. Cancer Immunotherapy market PEST analysis 4.5. Value Chain Analysis 4.6. Competitive Ranking Analysis, 2019 5. Cancer Immunotherapy Market Size and Forecast by Type 5.1. Global Cancer Immunotherapy market share by type, 2019 & 2026 5.2. Monoclonal Antibodies 5.2.1. Global monoclonal antibodies cancer immunotherapy market estimates and forecasts, 2015 - 2026 (USD Billion) 5.2.2. Global monoclonal antibodies cancer immunotherapy market estimates and forecasts, by region, 2015 - 2026 (USD Billion) 5.3. Cancer Vaccines 5.3.1. Global cancer vaccines cancer immunotherapy market estimates and forecasts, 2015 - 2026 (USD Billion) 5.3.2. Global cancer vaccines cancer immunotherapy market estimates and forecasts, by region, 2015 - 2026 (USD Billion) 5.4. Check Point Inhibitors & Immunomodulators 5.4.1. Global check point inhibitors & immunomodulators cancer immunotherapy market estimates and forecasts, 2015 - 2026 (USD Billion) 5.4.2. Global check point inhibitors & immunomodulators cancer immunotherapy market estimates and forecasts, by region, 2015 - 2026 (USD Billion) 6. Cancer Immunotherapy Market Size and Forecast by Application 6.1. Global Cancer Immunotherapy market share by application, 2019 & 2026 6.2. Lung Cancer 6.2.1. Global Cancer Immunotherapy market for Lung Cancer estimates and forecasts, 2015 - 2026 (USD Billion) 6.2.2. Global Cancer Immunotherapy for Lung Cancer market estimates and forecasts, by region, 2015 - 2026 (USD Billion) 6.3. Breast Cancer 6.3.1. Global Cancer Immunotherapy market for Breast Cancer estimates and forecasts, 2015 - 2026 (USD Billion) 6.3.2. Global Cancer Immunotherapy for Breast Cancer market estimates and forecasts, by region, 2015 - 2026 (USD Billion) 6.4. Colorectal Cancer 6.4.1. Global Cancer Immunotherapy market for Colorectal Cancer estimates and forecasts, 2015 - 2026 (USD Billion) 6.4.2. Global Cancer Immunotherapy market for Colorectal Cancer estimates and forecasts, by region, 2015 - 2026 (USD Billion) 6.5. Melanoma 6.5.1. Global Cancer Immunotherapy market for Melanoma estimates and forecasts, 2015 - 2026 (USD Billion) 6.5.2. Global Cancer Immunotherapy market for Melanoma estimates and forecasts, by region, 2015 - 2026 (USD Billion) 6.6. Prostate Cancer 4.2.1.2. 4.2.1.3. - 4 -

  5. Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 6.6.1. Global Cancer Immunotherapy market for Prostate Cancer estimates and forecasts, 2015 - 2026 (USD Billion) 6.6.2. Global Cancer Immunotherapy market for Prostate Cancer estimates and forecasts, by region, 2015 - 2026 (USD Billion) 6.7. Head and Neck 6.7.1. Global Cancer Immunotherapy market for head and neck estimates and forecasts, 2015 - 2026 (USD Billion) 6.7.2. Global Cancer Immunotherapy market for head and neck estimates and forecasts, by region, 2015 - 2026 (USD Billion) 7. Cancer Immunotherapy Market Size and Forecast by End-user 7.1. Global Cancer Immunotherapy market share by end-user, 2019 & 2026 7.2. Hospitals 7.2.1. Global Cancer Immunotherapy market for Hospitals as end-user, estimates and forecasts, 2015 - 2026 (USD Billion) 7.2.2. Global Cancer Immunotherapy market for Hospitals as end-user, estimates and forecasts, by region, 2015 - 2026 (USD Billion) 7.3. Clinics 7.3.1. Global Cancer Immunotherapy market for Clinics as end-user, estimates and forecasts, 2015 - 2026 (USD Billion) 7.3.2. Global Cancer Immunotherapy market for Clinics as end-user, estimates and forecasts, by region, 2015 - 2026 (USD Billion) 7.4. Others 7.4.1. Global Cancer Immunotherapy market for Other end-user, estimates and forecasts, 2015 - 2026 (USD Billion) 7.4.2. Global Cancer Immunotherapy market for Other end-user, estimates and forecasts, by region, 2015 - 2026 (USD Billion) 8. Cancer Immunotherapy Market Size and Forecast by Region 8.1. Global cancer immunotherapy market share by region, 2019 & 2026 8.2. North America 8.2.1. North America cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.2.2. North America cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.2.3. North America cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.2.4. U.S. 8.2.4.1. U.S. cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.2.4.2. U.S. cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.2.4.3. U.S. cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.2.5. Canada 8.2.5.1. Canada cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.2.5.2. Canada cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.2.5.3. Canada cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.3. Europe 8.3.1. Europe cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.3.2. Europe cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.3.3. Europe cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.3.4. Germany - 5 -

  6. Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 Germany cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.3.4.2. Germany cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.3.4.3. Germany cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.3.5. UK 8.3.5.1. UK cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.3.5.2. UK cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.3.5.3. UK cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.3.6. France 8.3.6.1. France cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.3.6.2. France cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.3.6.3. France cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.3.7. Italy 8.3.7.1. Italy cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.3.7.2. Italy cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.3.7.3. Italy cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.3.8. Spain 8.3.8.1. Spain cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.3.8.2. Spain cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.3.8.3. Spain cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.4. Asia Pacific 8.4.1. Asia Pacific cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.4.2. Asia Pacific cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.4.3. Asia Pacific cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.4.4. China 8.4.4.1. China cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.4.4.2. China cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.4.4.3. China cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.4.5. South Korea 8.4.5.1. South Korea cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.4.5.2. South Korea cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.4.5.3. South Korea cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.4.6. Japan 8.4.6.1. Japan cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.4.6.2. Japan cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.3.4.1. - 6 -

  7. Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 Japan cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.4.7. India 8.4.7.1. India cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.4.7.2. India cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.4.7.3. India cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.5. Latin America 8.5.1. Latin America cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.5.2. Latin America cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.5.3. Latin America cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.5.4. Brazil 8.5.4.1. Brazil cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.5.4.2. Brazil cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.5.4.3. Brazil cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.5.5. Mexico 8.5.5.1. Mexico cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.5.5.2. Mexico cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.5.5.3. Mexico cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.5.6. Colombia 8.5.6.1. Colombia cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.5.6.2. Colombia cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.5.6.3. Colombia cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.6. Middle East & Africa 8.6.1. MEA cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.6.2. MEA cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.6.3. MEA cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.6.4. Saudi Arabia 8.6.4.1. Saudi Arabia cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.6.4.2. Saudi Arabia cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.6.4.3. Saudi Arabia cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.6.5. South Africa 8.6.5.1. South Africa cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.6.5.2. South Africa cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.6.5.3. South Africa cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.6.6. Israel 8.4.6.3. - 7 -

  8. Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 Israel cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.6.6.2. Israel cancer immunotherapy market by type (USD Billion), 2015 - 2026 8.6.6.3. Israel cancer immunotherapy market by application (USD Billion), 2015 - 2026 8.6.7. UAE 8.6.7.1. UAE cancer immunotherapy market by end-user (USD Billion), 2015 - 2026 8.6.7.2. UAE cancer immunotherapy market by type (USD Billion), 2015 – 2026 8.6.7.3. UAE cancer immunotherapy market by application (USD Billion), 2015 – 2026 9. Company Profiles 9.1. Amgen Inc. 9.1.1. Overview 9.1.2. Financials 9.1.3. Product Benchmarking 9.1.4. Recent Developments 9.2. Astellas Pharma, Inc. 9.2.1. Overview 9.2.2. Financials 9.2.3. Product Benchmarking 9.2.4. Recent Developments 9.3. AstraZeneca PLC 9.3.1. Overview 9.3.2. Financials 9.3.3. Product Benchmarking 9.3.4. Recent Developments 9.4. Bayer AG 9.4.1. Overview 9.4.2. Financials 9.4.3. Product Benchmarking 9.4.4. Recent Developments 9.5. Bristol-Myers Squibb 9.5.1. Overview 9.5.2. Financials 9.5.3. Product Benchmarking 9.5.4. Recent Developments 9.6. Eli Lilly and Co. 9.6.1. Overview 9.6.2. Financials 9.6.3. Product Benchmarking 9.6.4. Recent Developments 9.7. Hoffman La Roche 9.7.1. Overview 9.7.2. Financials 9.7.3. Product Benchmarking 9.7.4. Recent Developments 9.8. Merck and Co. 9.8.1. Overview 9.8.2. Financials 9.8.3. Product Benchmarking 9.8.4. Recent Developments 8.6.6.1. - 8 -

  9. Cancer Immunotherapy Market Size Worth $117.82 Billion By 2026 9.9. Novartis 9.9.1. Overview 9.9.2. Financials 9.9.3. Product Benchmarking 9.9.4. Recent Developments 9.10. OSE Immunotherapeutics 9.10.1. Overview 9.10.2. Financials 9.10.3. Product Benchmarking 9.10.4. Recent Developments Access Press Release on Cancer Immunotherapy Market: https://www.polarismarketresearch.com/press-releases/cancer-immunotherapy-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com/ - 9 -

More Related